Sblendorio Glenn Insider Trades

Insider Trading History

Track insider trading activity for Sblendorio Glenn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$658k 45,423 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$615k 42,467 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$290k 20,000 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.08M 74,872 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$442k 30,474 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$523k 36,111 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$282k 19,473 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.07M 142,564 shares
$14.50
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$269k 18,574 shares
$14.49
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Apr 27, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$235k 16,236 shares
$14.49
$14.49
Mineralys Therapeutics
Mineralys Therapeutics MLYS
Director
Holding Value $155k 6,200 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 6,200 shares
$28.06
$25.06
Mineralys Therapeutics
Mineralys Therapeutics MLYS
Director
Holding Value $208k 8,300 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 8,300 shares
$28.06
$25.06
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $429k 45,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 45,000 shares
$7.30
$9.53
4D Molecular Therapeutics
4D Molecular Therapeutics FDMT
Director
Holding Value $0 0 shares
Last Trade
Jan 05, 2026 Sale
$88.9k 11,250 shares
$7.90
$9.53
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.68M 115,857 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 74,872 shares
$5.96
$14.49
Mineralys Therapeutics
Mineralys Therapeutics MLYS
Director
Holding Value $824k 32,900 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 32,900 shares
$10.20
$25.06
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.38M 95,443 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 42,467 shares
$10.27
$14.49
Mineralys Therapeutics
Mineralys Therapeutics MLYS
Director
Holding Value $551k 22,000 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 22,000 shares
$12.52
$25.06
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $1.21M 83,596 shares
Last Trade
Mar 07, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 15,000 shares
$12.29
$14.49
Amicus Therapeutics
Amicus Therapeutics FOLD
Director
Holding Value $0 0 shares
Last Trade
Mar 07, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$184k 15,000 shares
$12.29
$14.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up